The new resin is a designed tool for the GMP-regulated purification of antibodies and antibody fragments that contain a lambda light chain.
GE Healthcare Life Sciences custom design media director Henrik Ihre said collaborating with the team at BAC has resulted in a ready-to-use product for all human antibody formats containing a lambda light chain.
BAC CEO Laurens Sierkstra said LambdaFabSelect enables bioprocess engineers to use BAC’s ligand technology to produce Fab fragments with a lambda light chain for clinical and commercial use.
"It provides greater flexibility in the purification of these important biotherapeutics," added Sierkstra.